Last reviewed · How we verify
Rivaroxaban 10 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Rivaroxaban 10 mg (Rivaroxaban 10 mg) — Hospital Alemão Oswaldo Cruz.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Rivaroxaban 10 mg TARGET | Rivaroxaban 10 mg | Hospital Alemão Oswaldo Cruz | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Rivaroxaban 10 mg CI watch — RSS
- Rivaroxaban 10 mg CI watch — Atom
- Rivaroxaban 10 mg CI watch — JSON
- Rivaroxaban 10 mg alone — RSS
Cite this brief
Drug Landscape (2026). Rivaroxaban 10 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/rivaroxaban-10-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab